Equitable Holdings Inc. purchased a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 12,651 shares of the conglomerate's stock, valued at approximately $9,109,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Main Street Group LTD purchased a new position in shares of Danaher during the first quarter valued at approximately $25,000. N.E.W. Advisory Services LLC bought a new stake in Danaher in the second quarter valued at $25,000. JPL Wealth Management LLC bought a new stake in Danaher in the third quarter valued at $25,000. WFA of San Diego LLC purchased a new position in Danaher during the 2nd quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in Danaher in the 4th quarter worth $27,000. Hedge funds and other institutional investors own 79.05% of the company's stock.
Danaher Stock Up 0.2%
NYSE:DHR opened at $215.74 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm's 50-day moving average price is $198.69 and its 200-day moving average price is $192.35. The company has a market capitalization of $151.67 billion, a PE ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. During the same period last year, the company posted $0.77 EPS. Danaher's revenue was up 5.5% on a year-over-year basis. On average, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
DHR has been the topic of a number of research reports. Piper Sandler started coverage on shares of Danaher in a research note on Thursday, June 11th. They set a "neutral" rating and a $200.00 target price on the stock. Weiss Ratings raised shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, July 15th. TD Cowen lowered their price objective on shares of Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. Finally, Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They set a "buy" rating and a $230.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $228.91.
Read Our Latest Research Report on DHR
Danaher Company Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
